Byotrol PLC Annual General Meeting -- update on arrangements (5420E)
November 06 2020 - 6:27AM
UK Regulatory
TIDMBYOT
RNS Number : 5420E
Byotrol PLC
06 November 2020
6 November 2020
Byotrol plc
Annual General Meeting - update on arrangements
Byotrol's AGM is to be held at the offices of finnCap Ltd, 1
Bartholomew Close, London EC1A 7BL at 11.00 am on 13 November 2020.
As previously announced, shareholders should note that, due to the
COVID-19 pandemic, the AGM is being held as a closed meeting.
Shareholders (other than the minimum number of two required to form
a quorum, as arranged by the Company) will not be able to attend
and vote at the AGM in person.
The Board strongly advises shareholders to vote by proxy,
appointing the chairman of the meeting, in accordance with the
Notice of the AGM. In order to provide shareholders the opportunity
to ask questions which would normally be put to management in
person at the AGM and so that questions can be fully answered
following the completion of the formal business of the AGM, the
Board would request questions to be submitted in advance, before
5pm (GMT) on Thursday 12 November 2020. Questions should be sent to
investorrelations@byotrol.com , with the word "AGM" in the
title.
Questions will be considered by the Board and responses provided
where practical via the Company website. In accordance with normal
practice, the results of the AGM will be issued in a regulatory
news announcement and posted on the Company's website.
Enquiries:
Byotrol plc
David Traynor - Chief Executive Officer
Nic Hellyer - Chief Financial Officer 01925 742 000
finnCap
Geoff Nash/Kate Bannatyne - Corporate Finance 020 7220 0500
Richard Chambers - ECM
Flagstaff Strategic and Investor Communications
Tim Thompson/Andrea Seymour/Fergus Mellon 020 7129 1474
byotrol@flagstaffcomms.com
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection
prevention and control company, operating globally in the
Healthcare, Industrial, Food and Consumer sectors, providing low
toxicity products with a broad-based and targeted efficacy across
all microbial classes; bacteria, viruses (including coronavirus),
fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients
within existing products, where they can significantly improve
their performance, especially in personal hygiene, domestic and
industrial disinfection, odour control, food production and food
management.
Byotrol develops and commercialises technologies that create
easier, safer and cleaner lives for everyone.
For more information, please go to byotrol.co.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAUPGAPGUPUGGQ
(END) Dow Jones Newswires
November 06, 2020 06:27 ET (11:27 GMT)
Byotrol (LSE:BYOT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Byotrol (LSE:BYOT)
Historical Stock Chart
From Apr 2023 to Apr 2024